Resistance Training in Relapsing-Remitting Multiple Sclerosis

被引：1
|
作者：
Dalgas, U. [1 ]
Kant, M.
Stenager, E. [2 ]
机构：
[1] Univ Aarhus, Dept Sport Sci, DK-8000 Aarhus C, Denmark
[2] Univ So Denmark, Inst Reg Hlth Serv Res, Odense, Denmark
来源：
AKTUELLE NEUROLOGIE | 2010年 / 37卷 / 05期
关键词：
exercise therapy; strength training; fatigue; quality of life; rehabilitation; QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; GAIT KINEMATICS; EXERCISE; STRENGTH; PEOPLE; FATIGUE; RISK;
D O I：
10.1055/s-0030-1248526
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
This review summarises the existing knowledge regarding the effects of resistance training in patients suffering from relapsing-remitting multiple sclerosis (MS). Also, the literature concerning the effects of exercise on both the MS animal model and the immune system in MS patiente are reviewed. It is concluded that resistance training is a safe and beneficial exercise modality inmoderately impaired MS patients, potentially improving muscle strength, muscle mass, functional capacity, fatigue, mood and quality of life. Exercise may influence the disease progression in MS patients, but further studies are needed.
引用
收藏
页码：213 / 218
页数：6
相关论文
共 50 条
  • [11] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [12] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [13] Metabolomic profiling in relapsing-remitting multiple sclerosis
    Patel, Y.
    Vingara, L.
    Li, Y.
    Yu, H. J.
    Wagshul, M.
    Pelczer, I.
    Christodoulou, C.
    Melville, P.
    Maletic-Savatic, M.
    Krupp, L.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S80 - S80
  • [14] Cladribine TabletsIn Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    [J]. CNS Drugs, 2011, 25 : 239 - 249
  • [15] Immunomonitoring measures in relapsing-remitting multiple sclerosis
    Matsui, M
    Araya, S
    Wang, HY
    Matsushima, K
    Saida, T
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 148 (1-2) : 192 - 199
  • [16] Oral fumarate for relapsing-remitting multiple sclerosis
    Sorensen, Per Soelberg
    Sellebjerg, Finn
    [J]. LANCET, 2008, 372 (9648): : 1447 - 1448
  • [17] Quality of life in relapsing-remitting multiple sclerosis
    Dayapoglu, Nuray
    Tan, Mehtap
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (01) : 133 - 137
  • [18] Fatigue in multiple sclerosis relapsing-remitting form
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Felipe, E
    Moreira, MA
    Barao-Cruz, AM
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2000, 58 (2B) : 471 - 475
  • [19] Ibudilast in relapsing-remitting multiple sclerosis A neuroprotectant?
    Barkhof, F.
    Hulst, H. E.
    Drulovic, J.
    Uitdehaag, B. M. J.
    Matsuda, K.
    Landin, R.
    [J]. NEUROLOGY, 2010, 74 (13) : 1033 - 1040
  • [20] Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis
    M. C. Buscarinu
    S. Romano
    R. Mechelli
    R. Pizzolato Umeton
    M. Ferraldeschi
    A. Fornasiero
    R. Reniè
    B. Cerasoli
    E. Morena
    C. Romano
    N. D. Loizzo
    R. Umeton
    M. Salvetti
    G. Ristori
    [J]. Neurotherapeutics, 2018, 15 : 68 - 74
12345